Loading university
Theodore J. Price — Dr. Theodore Price's research lab focuses on understanding the molecular mechanisms behind chronic pain using human tissue samples. By analyzing the first neurons in the pain pathway, they aim to develop new therapeutic targets for pain management. The lab uses innovative techniques like CRISPR screening to conduct functional genomic studies, connecting molecular findings to real human pain conditions.
Amy Pinkham — Dr. Amy Pinkham's lab at the University of Texas Dallas focuses on understanding social cognition in individuals at high risk for psychosis. The research aims to develop and validate sensitive measures of social cognition that can help identify people at risk of developing psychotic disorders. This work is essential for improving treatment strategies and understanding how social cognitive performance relates to real-world outcomes for young individuals facing these challenges.
Rudi Fasan — Dr. Rudi Fasan's lab at the University of Texas Dallas focuses on creating new methods for discovering and synthesizing bioactive molecules, especially cyclic peptides, which can modulate biomolecular interactions with high precision. Their innovative approaches combine chemistry and biology to develop new catalysts and platforms that streamline drug discovery processes and enhance our understanding of complex biological systems.
Yongsheng Gao — Dr. Yongsheng Gao's lab at the University of Texas Dallas is focused on developing innovative synthetic materials to help manage traumatic bleeding in emergency situations. By creating microgel-based synthetic platelets that mimic the properties of natural platelets, the lab aims to improve the way we stop bleeding at injury sites. This research has significant implications for trauma care, potentially saving lives in critical situations.
Robert L Rennaker — Dr. Robert Rennaker's lab focuses on improving recovery after spinal cord injuries, particularly in restoring walking abilities. They utilize a technique called vagus nerve stimulation alongside rehabilitation exercises to promote healing and functional recovery in patients. The lab is involved in clinical trials to evaluate the effectiveness of these innovative therapies in helping individuals regain mobility and improve their quality of life.
Zhenpeng Qin — Dr. Zhenpeng Qin's lab at the University of Texas Dallas focuses on innovative methods for delivering therapeutic molecules specifically to neurons and spinal cord tumors. By developing a peptide that can target neurons across various animal species and employing light-based techniques to modulate the blood-spinal cord barrier, the lab aims to enhance drug delivery for neurological diseases and cancers affecting the spinal cord. This work has significant implications for improving treatment options and understanding of central nervous system disorders.
David W Schmidtke — David W Schmidtke's research lab at the University of Texas Dallas focuses on understanding how the immune system behaves in patients with ventricular assist devices (VADs) who are at risk for infections. They aim to identify biomarkers that predict infections and develop innovative tools to assess immune function in these patients. The lab's goal is to improve patient outcomes by exploring new therapies that can enhance the immune response and reduce infection rates in individuals with heart failure.
Noa Ofen — Dr. Noa Ofen's research lab at the University of Texas Dallas studies how children develop memory skills and the brain processes involved. They use advanced techniques like intracranial EEG and fMRI to understand how memory retrieval works in children, especially those with epilepsy. By delving into the brain’s memory networks, the lab aims to create effective interventions for memory problems in children, potentially improving their quality of life.
Xintong Dong — Dr. Xintong Dong's lab at the University of Texas Dallas focuses on understanding how the body defends against urinary tract infections (UTIs) caused by bacteria. The lab works on a type of immune molecule called defensins to see how they protect the urinary tract and potentially cause discomfort. By using advanced genetic techniques and mouse models, the lab aims to develop new therapies to improve outcomes for patients suffering from UTIs and the pain they may cause.